Online ISSN: 2355-8989, Print ISSN: 2088-0197

Indonesian Journal of Cancer Chemoprevention (IJCC) is an open access, peer-reviewed, triannual journal devoted to publishing articles on Cancer Chemoprevention including Experimental and Clinical Pharmacology, especially concerning Anti-Oxidants, Anti-Aging, Anti-Inflammation, Anti-Angiogenesis, and Anti-Carcinogenesis; Cancer Detection; Stem Cell Biology; Immunology; in vitro and in silico Exploration of Chemopreventive Mechanism; and Natural Products.

IJCC is an official journal of the Indonesian Society for Cancer Chemoprevention. All lJCC's materials are free to be copied and redistributed in any medium or format. However, appropriate credit should be given. The material may not be used for commercial purposes. This content licensing is in accordance with a CC license: CC-BY-NC.

To ensure the sustainability of our open access format and to support ongoing web maintenance, authors are charged a publication fee (APC) for each accepted manuscript. Starting from Volume 15 Issue 3, October 2024, the publication fee has changed as follows:

• For general authors: IDR 2,000,000
• For active ISCC member authors: IDR 1,000,000

IJCC has been accredited SINTA 1 by the Ministry of Higher Education, Science, and Technology of the Republic of Indonesia (SK Nomor 10/C/C3/DT.05.00/2025 tentang Peringkat Akreditasi Jurnal Ilmiah Periode 1 Tahun 2025)

Announcements

Indexed by:

Indonesian Society for Cancer Chemoprevention